A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

February 26, 2024

Primary Completion Date

March 10, 2025

Study Completion Date

April 14, 2025

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Insulin icodec

Participants will receive insulin icodec subcutaneous (s.c.) once weekly.

DRUG

Insulin degludec

Participants will receive insulin degludec s.c. once daily.

Trial Locations (1)

Medical University of Graz, Graz